A new artificial intelligence tool can predict pancreatic cancer up to three years before diagnosis, according to a study published in Nature Medicine on May 1, 2026. The AI model, developed by researchers at Harvard Medical School and the University of Copenhagen, analyzed electronic health records from 6.2 million patients in Denmark and the United States.
The algorithm identified individuals at high risk for pancreatic cancer by detecting subtle patterns in medical history, including diagnoses, medications, and lab results. In testing, the AI flagged patients who later developed the disease with 78% accuracy for cases occurring within 6 months, and 65% accuracy for cases up to 3 years ahead.
Pancreatic cancer is one of the deadliest cancers, with a 5-year survival rate of only 12%, largely because it is often detected late. The study's lead author, Dr. Chris Sander, noted that early detection could significantly improve outcomes, though the tool requires further validation before clinical use.
The AI system is not yet available for routine screening, but researchers plan to test it in clinical trials starting in 2027. The study was funded by the National Institutes of Health and the Novo Nordisk Foundation.
